Artwork for podcast Pathfinders in Biopharma
Biotech Halftime Report: A Winding Road Ahead
Episode 1526th September 2023 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:17:26

Share Episode

Shownotes

Join Head of US Capital Markets Research, Mark Odendahl and biotech analysts Brian Abrahams and Gregory Renza, as they explore the dynamic biotech sector landscape in H2 2023.

This episode was originally broadcast on Industries in Motion, the RBC podcast.

Follow

Links

Chapters

Video

More from YouTube